ARCHIVES

Bunn Says ASCO Is “Strong, Diverse, Respected, Growing”

This article is from The Cancer Letter archive.

Vol. 29 No. 23 | June 6, 2003

Download PDF Visit The Full Archive

Related Articles

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

L.I. Center At Stony Brook’s Goal Is Comprehensive Status.

October 27, 2000

In Brief: Hisserich Named USC Assistant VP, Replaced By Rideout At Cancer Center; DeVita Assures Groups

June 27, 1986

FDA Expands Nexavar Indication To Include Thyroid Cancer

December 27, 2013

NCI Grants: BSA Subcommittee Recommends Review Of SPORE Program In Year 2000

June 26, 1998

Dingell: “Unable To Vouch” For Staff Report On NCI’s Gallo

February 10, 1995